Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/33175
Type
ArticleCopyright
Restricted access
Embargo date
2050-01-01
Collections
Metadata
Show full item record
TRADITION AND INNOVATION IN DEVELOPMENT OF A ZIKA VACCINE
Vacinas
Vacinas virais / imunologia
Zika Virus / imunologia
Infecção por zika vírus / imunologia
Affilliation
University of Pittsburgh. School of Public Health. Center for Vaccine Research. Pittsburgh, PA, USA / Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, PE, Brasil.
University of Pittsburgh. School of Public Health. Center for Vaccine Research. Pittsburgh, PA, USA / Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, PE, Brasil.
University of Pittsburgh. School of Public Health. Center for Vaccine Research. Pittsburgh, PA, USA / Fundação Oswaldo Cruz. Instituto Aggeu Magalhães. Laboratório de Virologia e Terapia Experimental. Recife, PE, Brasil.
Abstract
Comment on Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
DeCS
HumanosVacinas
Vacinas virais / imunologia
Zika Virus / imunologia
Infecção por zika vírus / imunologia
Share